The Genomic Medicine Institute is committed to performing translational and clinical human genetics and genomics investigation and fostering innovation toward realizing the benefits of personalized genomic-based healthcare.
Cleveland Clinic Researchers Discover Distinct Genomic Characteristics of Breast Cancer in Women with PTEN Hamartoma Tumor Syndrome
08/05/2022
A research team led by Dr. Charis Eng has uncovered genomic characteristics of breast cancers associated with PTEN hamartoma tumor syndrome that differentiate them from sporadic breast cancers.
Read More
Researchers Map Human Ureter Cell Populations to Pave the Way for Regenerative Medicine
08/03/2022
A multidisciplinary research team co-led by Dr. Angela Ting and Dr. Byron Lee has conducted a comprehensive analysis of the cell populations within the human ureter.
Read More
Refining Thyroid Cancer Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome
07/11/2022
A study led by Dr. Eng suggests that patients with PTEN hamartoma tumor syndrome may require less frequent thyroid cancer surveillance than current guidelines recommend.
Read More9.15.22 | 8:00 AM – 4:25 PM ET | InterContinental Hotel and Bank of America Conference Center & Live Stream
This activity has been approved for AMA PRA Category 1 Credits™, ANCC Contact Hours, and AAPA Category 1 CME Credits